Clinical trial

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07031154

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-06-30

PhasePHASE2

Study timeline

Study start (estimated)2025-06-30Date precision: day

Registry last updated2025-06-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Adebrelimabunresolved

Apatinibunresolved

Interventions

AdebrelimabDRUG

ApatinibDRUG

Sponsors & collaborators

The First Affiliated Hospital of Xiamen Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07031154 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.